464 related articles for article (PubMed ID: 30219819)
21. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-211 triggers an autophagy-dependent apoptosis in cervical cancer cells: regulation of Bcl-2.
Liu S; Wang H; Mu J; Wang H; Peng Y; Li Q; Mao D; Guo L
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):359-370. PubMed ID: 31637455
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-96-5p Facilitates the Viability, Migration, and Invasion and Suppresses the Apoptosis of Cervical Cancer Cells byNegatively Modulating SFRP4.
Zhang H; Chen R; Shao J
Technol Cancer Res Treat; 2020; 19():1533033820934132. PubMed ID: 32527205
[TBL] [Abstract][Full Text] [Related]
24. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
Wang F; Shan S; Huo Y; Xie Z; Fang Y; Qi Z; Chen F; Li Y; Sun B
Int J Biochem Cell Biol; 2018 Jun; 99():91-99. PubMed ID: 29627439
[TBL] [Abstract][Full Text] [Related]
25. CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8.
Liu J; Wang D; Long Z; Liu J; Li W
Cell Physiol Biochem; 2018; 48(1):173-184. PubMed ID: 30007986
[TBL] [Abstract][Full Text] [Related]
26. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
29. lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.
Zou MJ; Cheng XR; Liu RF
J Obstet Gynaecol Res; 2022 Jul; 48(7):1836-1847. PubMed ID: 35388952
[TBL] [Abstract][Full Text] [Related]
30. Influence of hsa-miR-6727-5p on the proliferation, apoptosis, invasion and migration of Caski, Hela and SiHa cervical cancer cells.
Liu H; Pei G; Song M; Dai S; Wang Y
J BUON; 2017; 22(4):973-978. PubMed ID: 28952216
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.
Liu M; Jia J; Wang X; Liu Y; Wang C; Fan R
Cancer Biol Ther; 2018 May; 19(5):391-399. PubMed ID: 29336659
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433
[TBL] [Abstract][Full Text] [Related]
33. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.
Han X; Zhen S; Ye Z; Lu J; Wang L; Li P; Li J; Zheng X; Li H; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2017; 41(3):973-986. PubMed ID: 28222434
[TBL] [Abstract][Full Text] [Related]
34. A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p.
El Majzoub R; Fayyad-Kazan M; Nasr El Dine A; Makki R; Hamade E; Grée R; Hachem A; Talhouk R; Fayyad-Kazan H; Badran B
Genes Genomics; 2019 Dec; 41(12):1431-1443. PubMed ID: 31541355
[TBL] [Abstract][Full Text] [Related]
35. MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.
Liu YJ; Zhou HG; Chen LH; Qu DC; Wang CJ; Xia ZY; Zheng JH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):87-95. PubMed ID: 30657550
[TBL] [Abstract][Full Text] [Related]
36. Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.
Luo C; Fan W; Jiang Y; Zhou S; Cheng W
Med Sci Monit; 2018 Apr; 24():2197-2209. PubMed ID: 29650944
[TBL] [Abstract][Full Text] [Related]
37. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
38. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
Zhao H; Hu GM; Wang WL; Wang ZH; Fang Y; Liu YL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7295-7306. PubMed ID: 31539116
[TBL] [Abstract][Full Text] [Related]
40. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer.
Yang D; Zhan M; Chen T; Chen W; Zhang Y; Xu S; Yan J; Huang Q; Wang J
Sci Rep; 2017 Mar; 7():43109. PubMed ID: 28256505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
